NDC 43598-142

Nelarabine

Nelarabine

Nelarabine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy's Laboratories, Inc.. The primary component is Nelarabine.

Product ID43598-142_4fb1d2e0-6994-6f56-3b37-ae1d6e925d1d
NDC43598-142
Product TypeHuman Prescription Drug
Proprietary NameNelarabine
Generic NameNelarabine
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-12-23
Marketing CategoryANDA /
Application NumberANDA216934
Labeler NameDr. Reddy's Laboratories, Inc.
Substance NameNELARABINE
Active Ingredient Strength5 mg/mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 43598-142-06

6 VIAL, SINGLE-DOSE in 1 CARTON (43598-142-06) > 50 mL in 1 VIAL, SINGLE-DOSE (43598-142-11)
Marketing Start Date2023-01-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Nelarabine" or generic name "Nelarabine"

NDCBrand NameGeneric Name
43598-142NelarabineNelarabine
70710-1726NelarabineNelarabine
70710-1839NelarabineNelarabine
70771-1685NelarabineNelarabine
0078-0683Arranonnelarabine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.